2016 American Transplant Congress
Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) Protects Against Loss of Hepatic Integrity After Ischemia-Reperfusion Injury.
Surgery, The Dumont-UCLA Transplant Center, Los Angeles, CA.
Liver ischemia-reperfusion injury (IRI) remains a challenging problem in clinical orthotopic liver transplantation (OLT). Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix (ECM)-associated protein…2016 American Transplant Congress
Sphingosine-1 Phosphate Receptor 1 Agonist SEW2871 Ameliorates Hepatocellular Injury on Ischemic Reperfusion in Mice: A New Therapeutic Target.
Introduction: We had reported that activated protein C (APC) administration had cytoprotective effects on hepatic ischemic reperfusion (IR) injury in rat and mice models. Recent…2016 American Transplant Congress
Amino Acid (AA) Metabolism During Liver Allograft Preservation Comparing Subnormothermic Machine Perfusion (MP) Against Cold Storage (CS).
University of Pittsburgh, Pittsburgh.
Introduction: Liver is the major site for nitrogen metabolism. Most hepatic transcriptional activity is related to protein-specific synthesis. Liver preservation has a direct impact in…2016 American Transplant Congress
Peri-Operative Events and Complications in Minimally-Invasive Live Donor Nephrectomy: What Should We Tell Potential Donors?
Erasmus MC, University Medical Center, Rotterdam, Netherlands.
PURPOSE: To systematically assess perioperative events in minimally-invasive live donor nephrectomy, and to compare different techniques currently employed for this procedure.METHODS: A literature search was…2016 American Transplant Congress
Do We Need Radioisotope Renography in Evaluation of Split Renal Function in Living Kidney Donors?
Introduction: Accurate estimation of split renal function in living kidney donors is important for side-selection and a sufficient long-term residual renal function. The present study…2016 American Transplant Congress
The Impact of Total Ischaemic Time, Donor Age and the Pathway of Donor Death on Graft Outcomes After Deceased Donor Kidney Transplantation.
Prolonged ischaemia is a known risk factor for delayed graft function and its interaction with donor characteristics, the pathways of donor death and graft outcomes…2016 American Transplant Congress
Donor Interstitial Fibrosis and Tubular Atrophy (IFTA) Are Not Independent Risk Factors for a Lower GFR at One Year.
BackgroundDonor age is a determinant of allograft outcome after deceased donor kidney transplant (DDTx). Our aim was to determine if chronic changes on a reperfusion…2016 American Transplant Congress
Is Early Endoscopic Retrograde Cholangiopancreatography (ERCP) Safe Post Liver Transplant?
1Tampa General Hospital, Tampa, FL; 2University of South Florida School of Medicine, Tampa, FL.
Introduction: Biliary complications are the most common cause of morbidity post orthotopic liver transplant (OLT), occurring in 5-32% of this patient population. Endoscopic retrograde cholangiopancreatography…2016 American Transplant Congress
Outcomes of Aorto-Hepatic Conduit During Liver Transplantation – A 31-Year, Single Center Experience.
Baylor University Medical Center, Dallas, TX.
IntroductionCreation of aorto-hepatic conduits (AC) is often required during liver transplantation (LT). AC may be planned, or may be required urgently intraoperatively. This study was…2016 American Transplant Congress
Neuromuscular Stimulation Leads to Improved Lower Limb Edema and Blood Flow Compared to Standard Compression Devices Following Kidney and Pancreatic Transplantation.
Western University, London, Canada.
Introduction: Kidney and pancreas transplant recipients undergo significant fluid shifts in the post-operative period leading to significant lower limb edema. Intermittent compression (IPC) devices are…
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 180
- Next Page »